Showing results (11-20 of 406) with videos related to
Sort By:
Pageof 41
Journal of Pharmacobio-Dynamics|May 1, 1987
Variances in pharmacokinetic parameters due to assay methods for beta-methyldigoxinM Goto, A Suzuki, T Terashima, et al.Journal of Pharmacobio-Dynamics|October 1, 1987
Time-dependent pharmacokinetics of theophylline: failure of application of the test-dose conceptM Goto, I Johno, M Hasegawa, et al.European Journal of Clinical Pharmacology|January 1, 1987
Plasma free fatty acids and protein binding of disopyramide during haemodialysisT Horiuchi, I Johno, S Kitazawa, et al.European Journal of Clinical Pharmacology|January 1, 1989
Inhibitory effect of free fatty acids on plasma protein binding of disopyramide in haemodialysis patientsT Horiuchi, I Johno, T Hasegawa, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1990
Effect of diabetes on disposition and renal handling of cefazolin in ratsM Nadai, H Yoshizumi, T Kuzuya, et al.Journal of Pharmacobio-Dynamics|October 1, 1989
Assessment of clinical application of test-dose concept for theophylline in patients with respiratory failureM Goto, H Yoshida, T Terashima, et al.Therapeutic Drug Monitoring|January 1, 1988
Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?I Johno, T Kuzuya, K Suzuki, et al.Journal of Clinical and Hospital Pharmacy|September 1, 1984
Clinical evaluation of theophylline binding to plasma protein in bronchial asthmatic patientsI Johno, Y Ogura, T Hasegawa, et al.Masui. the Japanese Journal of Anesthesiology|June 1, 1991
[Effects of prostaglandin E1 on vecuronium and fentanyl pharmacokinetics in humans]T Ishii, S Moriyama, I JohnoEuropean Journal of Drug Metabolism and Pharmacokinetics|October 8, 1999
Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletineH Konishi, K Morita, T Minouchi, et al.Pageof 41